“…In cataract surgery, intracameral cefuroxime (ICC) became widely accepted, following a multicentre study by the European Society of Cataract and Refractive Surgeons (ESCRS) which demonstrated that ICC administration reduced the incidence of post-op endophthalmitis by five-fold. 1 However, there have been reports of ocular toxicity with standard (1mg/0.1mL) 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 and high doses (2–100mg) of ICC, 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 including retinal toxicity, corneal toxicity and uveitis, with a risk of permanent visual loss from retinal structural damage. 7 , 14 , 21…”